CompletedNot Applicable

Gait Analysis in MPS IVA

United States10 participantsStarted 2013-08

Plain-language summary

The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and possible changes in gait with enzyme replacement therapy.

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Measurable changes in gait

Timeframe: 36 months

NCT IDNCT01920828

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-06